| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |